PhaseBio Pharmaceuticals, Inc. (PHAS): Price and Financial Metrics


PhaseBio Pharmaceuticals, Inc. (PHAS)

Today's Latest Price: $4.65 USD

0.08 (-1.69%)

Updated Jul 8 6:55pm

Add PHAS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PHAS Daily Price Range
PHAS 52-Week Price Range

PHAS Stock Price Chart Technical Analysis Charts


PHAS Price/Volume Stats

Current price $4.65 52-week high $12.34
Prev. close $4.73 52-week low $2.60
Day low $4.49 Volume 321,800
Day high $4.89 Avg. volume 562,142
50-day MA $4.74 Dividend yield N/A
200-day MA $4.38 Market Cap 133.83M

PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio


PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.


PHAS Latest News Stream


Event/TimeNews Detail
Loading, please wait...

PHAS Latest Social Stream


Loading social stream, please wait...

View Full PHAS Social Stream

PHAS Price Returns

1-mo -9.36%
3-mo N/A
6-mo -31.52%
1-year -60.12%
3-year N/A
5-year N/A
YTD -23.90%
2019 97.73%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7971 seconds.